These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Use of metformin in polycystic ovary syndrome: a meta-analysis. Creanga AA; Bradley HM; McCormick C; Witkop CT Obstet Gynecol; 2008 Apr; 111(4):959-68. PubMed ID: 18378757 [TBL] [Abstract][Full Text] [Related]
4. Metformin for the treatment of the polycystic ovary syndrome. Barbieri RL; Gargiulo AR Minerva Ginecol; 2004 Feb; 56(1):63-79. PubMed ID: 14973411 [TBL] [Abstract][Full Text] [Related]
5. Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation. Goldenberg N; Glueck C Minerva Ginecol; 2008 Feb; 60(1):63-75. PubMed ID: 18277353 [TBL] [Abstract][Full Text] [Related]
6. Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome? Cheang KI; Sharma ST; Nestler JE Gynecol Endocrinol; 2006 Nov; 22(11):595-604. PubMed ID: 17145645 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome. Cristello F; Cela V; Artini PG; Genazzani AR Gynecol Endocrinol; 2005 Dec; 21(6):340-52. PubMed ID: 16390783 [TBL] [Abstract][Full Text] [Related]
8. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome. Checa MA; Requena A; Salvador C; Tur R; Callejo J; Espinós JJ; Fábregues F; Herrero J; Hum Reprod Update; 2005; 11(4):375-90. PubMed ID: 15878899 [TBL] [Abstract][Full Text] [Related]
9. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome. Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426 [TBL] [Abstract][Full Text] [Related]
10. Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome. Palomba S; Falbo A; Orio F; Tolino A; Zullo F Fertil Steril; 2009 Jun; 91(6):2557-67. PubMed ID: 18440534 [TBL] [Abstract][Full Text] [Related]
11. Insulin-sensitizing agents in women with polycystic ovary syndrome. Pasquali R; Gambineri A Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283 [TBL] [Abstract][Full Text] [Related]
12. [Treatment experience with metformin in polycystic ovary syndrome]. Petrányi G Orv Hetil; 2005 May; 146(21):1151-5. PubMed ID: 15991679 [TBL] [Abstract][Full Text] [Related]
13. Off-label drug use in the treatment of polycystic ovary syndrome. Vitek W; Alur S; Hoeger KM Fertil Steril; 2015 Mar; 103(3):605-11. PubMed ID: 25726702 [TBL] [Abstract][Full Text] [Related]
14. Polycystic ovarian syndrome--prognosis and outcomes. Hart R; Norman R Best Pract Res Clin Obstet Gynaecol; 2006 Oct; 20(5):751-78. PubMed ID: 16766228 [TBL] [Abstract][Full Text] [Related]
15. The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence. Leeman L; Acharya U J Obstet Gynaecol; 2009 Aug; 29(6):467-72. PubMed ID: 19697191 [TBL] [Abstract][Full Text] [Related]
19. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients. Palomba S; Falbo A; Orio F; Zullo F Curr Opin Obstet Gynecol; 2008 Aug; 20(4):364-73. PubMed ID: 18660688 [TBL] [Abstract][Full Text] [Related]
20. The role of metformin in the treatment of polycystic ovary syndrome (PCOS). Wang HS Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]